563 Publications (Page 13 of 23)
2014
IL-12/Th1 and IL-23/Th17 biliary microenvironment in primary biliary cirrhosis: implications for therapy.
Yang, Chen-Yen⋅Ma, Xiong⋅Tsuneyama, Koichi⋅Huang, Shanshan⋅Takahashi, Toru⋅Chalasani, Naga P⋅Bowlus, Christopher L⋅Yang, Guo-Xiang⋅Leung, Patrick S⋅Ansari, Aftab A⋅Wu, Linda⋅Coppel, Ross and Gershwin, M E
Hepatology (Baltimore, Md.), vol. 59, (no. 5), pp. 1944-53, 2014/May. | Journal Article
 
Management of dyslipidemia as a cardiovascular risk factor in individuals with nonalcoholic fatty liver disease.
Corey, Kathleen E and Chalasani, Naga
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, vol. 12, (no. 7), pp. 1077-84; quiz e59-60, July 2014. | Journal Article
 
Mo1993 Little Evidence for Serious Outcome in Patients With Chronic Liver Disease Receiving Potentially Hepatotoxic Drugs
Bjornsson, Einar⋅Einarsdottir, Rannveig⋅Jacobsen, Elin and Chalasani, Naga
Gastroenterology, vol. 146, (no. 5), pp. S-711, 2014. | Journal Article
 
Obesity associated molecular forms of C-reactive protein in human.
Asztalos, Bela F⋅Horan, Michael S⋅Horvath, Katalin V⋅McDermott, Ann Y⋅Chalasani, Naga P and Schaefer, Ernst J
PloS one, vol. 9, (no. 10), pp. e109238, 2014. | Journal Article
 
Relationship between changes in serum levels of keratin 18 and changes in liver histology in children and adults with nonalcoholic fatty liver disease.
Vuppalanchi, Raj⋅Vuppalanchi, Raj⋅Jain, Ajay⋅Jain, Ajay K⋅Deppe, Ross⋅Deppe, Ross⋅Yates, Katherine⋅Yates, Katherine⋅Comerford, Megan⋅Comerford, Megan⋅Masuoka, Howard⋅Masuoka, Howard C⋅Neuschwander-Tetri, Brent⋅Neuschwander-Tetri, Brent A⋅Loomba, Rohit⋅Loomba, Rohit⋅Brunt, Elizabeth⋅Brunt, Elizabeth M⋅Kleiner, David E⋅Kleiner, David⋅Molleston, Jean⋅Molleston, Jean P⋅Schwimmer, Jeffrey B⋅Schwimmer, Jeffrey⋅Lavine, Joel E⋅Lavine, Joel⋅Tonascia, James⋅Tonascia, James⋅Chalasani, Naga and Chalasani, Naga
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, vol. 12, (no. 12), pp. 2121-30.e1-2, December 2014. | Journal Article
 
Relationship between characteristics of medications and drug-induced liver disease phenotype and outcome.
Vuppalanchi, Raj⋅Gotur, Raghavender⋅Reddy, K Rajender⋅Fontana, Robert J⋅Ghabril, Marwan⋅Kosinski, Andrzej S⋅Gu, Jiezhun⋅Serrano, Jose and Chalasani, Naga
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, vol. 12, (no. 9), pp. 1550-1555, September 2014. | Journal Article
 
Serum hepcidin levels are associated with obesity but not liver disease.
Vuppalanchi, Raj K⋅Troutt, Jason S⋅Konrad, Robert J⋅Ghabril, Marwan S⋅Saxena, Romil⋅Bell, Lauren N⋅Kowdley, Kris V and Chalasani, Naga
Obesity (Silver Spring, Md.), vol. 22, (no. 3), pp. 836-41, 2014/Mar. | Journal Article
 
Serum Hepcidin Levels Are Associated With Obesity but Not Liver Disease
Vuppalanchi, Raj⋅Troutt, Jason⋅Konrad, Robert⋅Ghabril, Marwan⋅Saxena, Romil⋅Bell, Lauren⋅Kowdley, Kris and Chalasani, Naga
Obesity, vol. 22, (no. 3), pp. 836-841, Mar 2014. | Journal Article
 
Slow but steady progress in a field with many knowledge gaps.
Chalasani, Naga and Hayashi, Paul H
(pp. 113-114). May 2014
 
Spectrum of statin hepatotoxicity: experience of the drug-induced liver injury network.
Russo, Mark W⋅Hoofnagle, Jay H⋅Gu, Jiezhun⋅Fontana, Robert J⋅Barnhart, Huiman X⋅Kleiner, David E⋅Chalasani, Naga and Bonkovsky, Herbert L
Hepatology (Baltimore, Md.), vol. 60, (no. 2), pp. 679-86, 2014/Aug. | Journal Article
 
Trials and tribulations in drug development for nonalcoholic steatohepatitis.
Sanyal, Arun J and Chalasani, Naga
(pp. 2104-2105). December 2014
2013
379 Novel Genetic Loci Associated With Steatohepatitis and Fibrosis in Hispanic Boys With Nonalcoholic Fatty Liver Disease
Lavine, Joel⋅Lavine, Joel⋅Chalasani, Naga⋅Chalasani, Naga⋅Guo, Xiuqing⋅Guo, Xiuqing⋅Kwon, Soonil⋅Kwon, Soonil⋅Schwimmer, Jeffrey⋅Schwimmer, Jeffrey⋅Molleston, Jean⋅Molleston, Jean⋅Loomba, Rohit⋅Loomba, Rohit⋅Brunt, Elizabeth⋅Brunt, Elizabeth⋅Chen, Yii-Der⋅Chen, Yii-Der⋅Goodarzi, Mark⋅Goodarzi, Mark⋅Taylor, Kent⋅Taylor, Kent⋅Yates, Katherine⋅Yates, Katherine⋅Unalp, Aynur⋅Unalp, Aynur⋅Rotter, Jerome and Rotter, Jerome
Gastroenterology, vol. 144, (no. 5), pp. S-946, 2013. | Journal Article
 
518 Changes in Serum Cytokeratin 18 Levels Significantly Predict Changes in Liver Histology in Adults With Nonalcoholic Steatohepatitis: Results From the Pivens Trial
Vuppalanchi, Raj⋅Vuppalanchi, Raj⋅Vuppalanchi, Raj⋅Deppe, Ross⋅Deppe, Ross⋅Deppe, Ross⋅Yates, Katherine⋅Yates, Katherine⋅Yates, Katherine⋅Comerford, Megan⋅Comerford, Megan⋅Comerford, Megan⋅Masuoka, Howard⋅Masuoka, Howard⋅Masuoka, Howard⋅Tetri, Brent⋅Tetri, Brent⋅Tetri, Brent⋅Loomba, Rohit⋅Loomba, Rohit⋅Loomba, Rohit⋅Brunt, Elizabeth⋅Brunt, Elizabeth⋅Brunt, Elizabeth⋅Kleiner, David⋅Kleiner, David⋅Kleiner, David⋅Tonascia, James⋅Tonascia, James⋅Tonascia, James⋅Chalasani, Naga⋅Chalasani, Naga and Chalasani, Naga
Gastroenterology, vol. 144, (no. 5), pp. S-951, 2013. | Journal Article
 
519 Predictors of Mortality in Individuals With Nonalcoholic Fatty Liver Disease (NAFLD) in the United States: Results From the Third National Health and Nutrition Examination Survey (NHANES III)
Nutakki, Kavitha⋅Nutakki, Kavitha⋅Liangpunsakul, Suthat⋅Liangpunsakul, Suthat⋅Chalasani, Naga and Chalasani, Naga
Gastroenterology, vol. 144, (no. 5), pp. S-951, 2013. | Journal Article
 
925 Serum CK18 but Not HMGB1 Levels Are Elevated in Adults With Primary Sclerosing Cholangitis
Deppe, Ross⋅Deppe, Ross⋅Deppe, Ross⋅Deppe, Ross⋅Deppe, Ross⋅Comerford, Megan⋅Comerford, Megan⋅Comerford, Megan⋅Comerford, Megan⋅Comerford, Megan⋅Masuoka, Howard⋅Masuoka, Howard⋅Masuoka, Howard⋅Masuoka, Howard⋅Masuoka, Howard⋅Liangpunsakul, Suthat⋅Liangpunsakul, Suthat⋅Liangpunsakul, Suthat⋅Liangpunsakul, Suthat⋅Liangpunsakul, Suthat⋅Ghabril, Marwan⋅Ghabril, Marwan⋅Ghabril, Marwan⋅Ghabril, Marwan⋅Ghabril, Marwan⋅Chalasani, Naga⋅Chalasani, Naga⋅Chalasani, Naga⋅Chalasani, Naga⋅Chalasani, Naga⋅Vuppalanchi, Raj⋅Vuppalanchi, Raj⋅Vuppalanchi, Raj⋅Vuppalanchi, Raj and Vuppalanchi, Raj
Gastroenterology, vol. 144, (no. 5), pp. S-967, 2013. | Journal Article
 
Clinical liver disease
Wattacheril, Julia and Chalasani, Naga
Clinical liver disease, vol. 2, pp. 103-105, November 2013. | Journal Article
 
De novo malignancy post-liver transplantation: a single center, population controlled study.
Chatrath, Hemant⋅Berman, Kenneth⋅Vuppalanchi, Raj⋅Slaven, James⋅Kwo, Paul⋅Tector, A Joseph⋅Chalasani, Naga and Ghabril, Marwan
Clinical transplantation, vol. 27, (no. 4), pp. 582-590. | Journal Article
 
Drug-induced liver injury caused by intravenously administered medications: the Drug-induced Liver Injury Network experience.
Ghabril, Marwan⋅Fontana, Robert⋅Rockey, Don⋅Jiezhun, Gu and Chalasani, Naga
Journal of clinical gastroenterology, vol. 47, (no. 6), pp. 553-558, July 2013. | Journal Article
 
Epidemiology and risk factors of nonalcoholic fatty liver disease (NAFLD).
Duseja, Ajay and Chalasani, Naga
Hepatology international, vol. 7 Suppl 2, pp. 755-764, December 2013. | Journal Article
 
Factors that predict short-term intensive care unit mortality in patients with cirrhosis.
Bahirwani, Ranjeeta⋅Bahirwani, Ranjeeta⋅Ghabril, Marwan⋅Ghabril, Marwan⋅Forde, Kimberly A⋅Forde, Kimberly A⋅Chatrath, Hemant⋅Chatrath, Hemant⋅Wolf, Karen M⋅Wolf, Karen M⋅Uribe, Lindsay⋅Uribe, Lindsay⋅Reddy, K R⋅Reddy, K Rajender⋅Fuchs, Barry⋅Fuchs, Barry⋅Chalasani, Naga and Chalasani, Naga
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, vol. 11, (no. 9), pp. 1194-1200.e2, 2013/Sep. | Journal Article
 
Mo1012 Genetic Polymorphism of Cytochrome P450 4f2 (CYP4F2) and Histological Response to Vitamin E Treatment in Children and Adults With Nonalcoholic Fatty Liver Disease (NAFLD)
Athinarayanan, Shaminie⋅Athinarayanan, Shaminie⋅Athinarayanan, Shaminie⋅Wei, Rongrong⋅Wei, Rongrong⋅Wei, Rongrong⋅Bai, Shaochun⋅Bai, Shaochun⋅Bai, Shaochun⋅Traber, Maret⋅Traber, Maret⋅Traber, Maret⋅Yates, Katherine⋅Yates, Katherine⋅Yates, Katherine⋅Cummings, Oscar⋅Cummings, Oscar⋅Cummings, Oscar⋅Molleston, Jean⋅Molleston, Jean⋅Molleston, Jean⋅Chalasani, Naga⋅Chalasani, Naga⋅Chalasani, Naga⋅Liu, Wanqing⋅Liu, Wanqing and Liu, Wanqing
Gastroenterology, vol. 144, (no. 5), pp. S-1013, 2013. | Journal Article
 
NAFLD fibrosis score: is it ready for wider use in clinical practice and for clinical trials?
Gawrieh, Samer⋅Gawrieh, Samer⋅Chalasani, Naga and Chalasani, Naga
Gastroenterology, vol. 145, (no. 4), pp. 717-9, 2013/Oct. | Journal Article
 
Nonalcoholic fatty liver disease: an emerging threat to obese and diabetic individuals.
Masuoka, Howard C and Chalasani, Naga
Annals of the New York Academy of Sciences, vol. 1281, pp. 106-22, 2013/Apr. | Journal Article
 
Pharmacokinetic and pharmacodynamic alterations in the Roux-en-Y gastric bypass recipients.
Tandra, Sweta⋅Chalasani, Naga P⋅Jones, David R⋅Mattar, Samer⋅Hall, Stephen D and Vuppalanchi, Raj
Annals of surgery, vol. 258, (no. 2), pp. 262-9, 2013/Aug. | Journal Article
 
Pre-Liver Transplant Acute Kidney Injury and Post-Transplant Outcomes: Presidential Poster
Jackson, Mollie⋅Jackson, Mollie⋅Jackson, Mollie⋅Jackson, Mollie⋅Gondal, Maryam⋅Gondal, Maryam⋅Gondal, Maryam⋅Gondal, Maryam⋅Vuppalanchi, Raj⋅Vuppalanchi, Raj⋅Vuppalanchi, Raj⋅Vuppalanchi, Raj⋅Agrawal, Saurabh⋅Agrawal, Saurabh⋅Agrawal, Saurabh⋅Agrawal, Saurabh⋅Lacerda, Marco⋅Lacerda, Marco⋅Lacerda, Marco⋅Lacerda, Marco⋅Chalasani, Naga⋅Chalasani, Naga⋅Chalasani, Naga⋅Chalasani, Naga⋅Kwo, Paul⋅Kwo, Paul⋅Kwo, Paul⋅Kwo, Paul⋅Tector, Joseph A⋅Tector, Joseph A⋅Tector, Joseph A⋅Tector, Joseph A⋅Ghabril, Marwan⋅Ghabril, Marwan⋅Ghabril, Marwan and Ghabril, Marwan
American Journal of Gastroenterology, vol. 108, pp. S126, 2013-10-00. | Journal Article